Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

Rauscher, Gregory E., M.D. PA600 enrolled

Overview

Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the Spectrosense EVA system, which is combination of a gas chromatography (GC) and software algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the best discrimination between Breast Cancer sick population and healthy population. The gold standard for identifying sick/healthy population is biopsy proven breast cancer.

Study Type

OBSERVATIONAL

Enrollment

600

Conditions

Breast Cancer

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Breast Cancer group: Inclusion Criteria: * Age from 18 years old * Breast cancer positive biopsy * Before any treatment * Signed Informed Patient Consent Exclusion Criteria: * Age under 18 years old * Neoadjovant treatment * Post surgery for breast cancer * A history of any other cancer type, except skin cancer that is not melanoma Healthy group: Inclusion Criteria: * Healthy women * No history of Breast cancer * Signed Informed Patient Consent Exclusion Criteria: * History of Breast cancer * Breast cancer background in the family * A history of any other cancer type, except skin cancer that is not melanoma

Locations (1)

Englewood Hospital and Medical Center

Englewood, New Jersey, United States

RECRUITING

Outcomes

Primary Outcomes

Obtaining a set or sets of VOC bio-markers that will provide the best discrimination between Breast Cancer sick population and healthy population. breast cancer.

Time frame: Upon enrollment.

Central Contacts

Jamie Ketas

CONTACT

201-894-3418 Jamie.Ketas@ehmc.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.